Paid Clinical Trials San Francisco

Discover 2,144 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,144

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Recruiting

PHASE2

Sponsor:

New York Medical College

Location:

San Francisco, Los Angeles, Aurora, Saint Louisshow 5 more

Code:

NCT03266627

Conditions

Adenovirus

Primary Immune Deficiency Disorder

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

cytotoxic t-lymphocytes

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

Recruiting

PHASE1

PHASE2

Sponsor:

Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Location:

San Francisco, Los Angeles, Portland, Aurorashow 7 more

Code:

NCT04471727

Conditions

Small-Cell Lung Cancer

Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MK-6070

Atezolizumab

Ifinatamab Deruxtecan (I-DXd)

Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers

Recruiting

PHASE3

Sponsor:

Intercytex

Location:

San Francisco, Alameda, Castro Valley, Sacramentoshow 34 more

Code:

NCT00232973

Conditions

Leg Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ICXP007

Treating Major Depression With Yoga Mono-therapy

Recruiting

Sponsor:

UCLA

Location:

San Francisco

Code:

NCT06091527

Conditions

Depression Mild

Depression Moderate

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Yoga practice

Education

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

San Francisco, Reno, Lancaster, Los Angelesshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia

Recruiting

Sponsor:

Stanford University

Location:

Stanford

Code:

NCT05379673

Conditions

Ventilatory Depression

Postoperative Respiratory Failure

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Oxygen Gas for Inhalation

Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

Recruiting

PHASE3

Sponsor:

Keryx Biopharmaceuticals

Location:

San Francisco, Stanford, Salt Lake City, Phoenixshow 9 more

Code:

NCT04523727

Conditions

Hyperphosphatemia Related to Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 6 - 16

Healthy Volunteers: Not accepted

Interventions

ferric citrate

Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia

Recruiting

Sponsor:

Stanford University

Location:

Palo Alto

Code:

NCT04885127

Conditions

Acute Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Palliative Care + Digital Symptom Monitoring

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Recruiting

PHASE1

Sponsor:

Pediatric Brain Tumor Consortium

Location:

Palo Alto, Los Angeles, Houston, Chicagoshow 8 more

Code:

NCT04978727

Conditions

Medulloblastoma

Glioblastoma Multiforme

Anaplastic Astrocytoma

High-grade Astrocytoma NOS

Anaplastic Oligodendroglioma

Eligibility Criteria

Sex: All

Age: 1 - 21

Healthy Volunteers: Not accepted

Interventions

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years

SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years

Effect of Ketamine on Intraoperative Motor Evoked Potentials

Recruiting

PHASE3

Sponsor:

UCLA

Location:

San Francisco

Code:

NCT06140927

Conditions

Spine Fusion

Spine Tumor

Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ketamine